BluCon Biotech GmbH
Nattermannallee 1
50 829 Cologne
Web: www.blucon-biotech.com
Email: blucon@blucon-biotech.com
Authorised representative: Dr. Albrecht Läufer, Markus Fehr
Register court: local court Cologne, Germany
Commercial Register Köln HRB 92566
Umsatzsteuer ID: USt-IdNr. DE314846368.
A member of German-Sino Healthcare Group
BluCon Biotech GmbH is a company that has developed a unique technology for producing L-lactic acid at low costs. It uses proprietary bacteria to digest lignocellulosic biomass and produce lactic acid, the building block of PLA, in one bioreactor. The innovative fermentation process developed by the company directly converts these raw materials into L-lactic acid. This is the first time this has been done in the world. This technology has the potential to make bioplastics such as poly lactic acid (PLA) competitive with fossil-based plastics and can help reduce the amount of non-degradable plastic waste by replacing fossil based plastics with biodegradable, sustainable products. BluCon's technology uses agricultural and industrial residues instead of sugars, which avoids competition with the food chain. The technology has a significant positive impact on the environment, carbon footprint and circular economy, and aligns with the United Nations Sustainable Development Goals (SDGs).
SITEMAP
OUR OFFICE
BluCon Biotech GmbH
Nattermannallee 1
50 829 Cologne
Email: blucon@blucon-biotech.com